eIF4E overexpression was detected at a range of 3–30 fold in breast carcinomas, compared to normal breast tissue [8, 10], and eIF4E levels were significantly increased in vascularized malignant ductules of invasive carcinomas [33]. The gene discussed is EIF4E; the disease is invasive carcinoma.